Fulvestrant
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
71731-6121 -
Package NDC
71731-6121-1 -
Application number
ANDA211422 -
SPL ID
6cfbb5fe-940b-4ff1-89a7-e1dfc42b235b -
SPL set ID
46086fe7-190d-4963-97bc-1fe22d36e6d2 -
UNII
22X328QOC4 -
RxCUI
727762
What the source publishes
- Labeler
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
- Active ingredients
- fulvestrant
- Form
- INJECTION
- Routes
- INTRAMUSCULAR
- Administrative status
- present-in-source-snapshot
- Marketing status
- ANDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "Fulvestrant",
"splId": "6cfbb5fe-940b-4ff1-89a7-e1dfc42b235b",
"labels": [
{
"setId": "46086fe7-190d-4963-97bc-1fe22d36e6d2",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=46086fe7-190d-4963-97bc-1fe22d36e6d2",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=46086fe7-190d-4963-97bc-1fe22d36e6d2"
}
],
"routes": [
"INTRAMUSCULAR"
],
"labeler": "Chia Tai Tianqing Pharmaceutical Group Co., Ltd.",
"finished": true,
"packaging": [
{
"sample": false,
"description": "2 SYRINGE, GLASS in 1 CARTON (71731-6121-1) / 5 mL in 1 SYRINGE, GLASS",
"package_ndc": "71731-6121-1",
"identifierStatus": "well-formed",
"marketing_start_date": "20210401"
}
],
"productId": "71731-6121_6cfbb5fe-940b-4ff1-89a7-e1dfc42b235b",
"useDomain": "unknown",
"dosageForm": "INJECTION",
"productNdc": "71731-6121",
"deaSchedule": null,
"genericName": "fulvestrant",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "FULVESTRANT",
"strength": "50 mg/mL"
}
],
"applicationNumber": "ANDA211422",
"marketingCategory": "ANDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20210401",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"nui": [
"N0000175582",
"N0000000145",
"N0000000168"
],
"unii": [
"22X328QOC4"
],
"rxcui": [
"727762"
],
"spl_set_id": [
"46086fe7-190d-4963-97bc-1fe22d36e6d2"
],
"pharm_class_epc": [
"Estrogen Receptor Antagonist [EPC]"
],
"pharm_class_moa": [
"Estrogen Receptor Antagonists [MoA]",
"Selective Estrogen Receptor Modulators [MoA]"
],
"manufacturer_name": [
"Chia Tai Tianqing Pharmaceutical Group Co., Ltd."
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:71731-6121_6cfbb5fe-940b-4ff1-89a7-e1dfc42b235b"